uniQure N.V. (NASDAQ:QURE) is one of the stocks Jim Cramer recently talked about. A caller asked whether to buy, hold, or take profits in the stock after the release of clinical data, which indicated its gene therapy candidate significantly slowed the progression of Huntington’s disease. Cramer said: “Yeah, I saw that news and it was really terrific. But I also saw that an insider sold about $9 million worth of stock after the run. I think that’s a, it’s a parabola, and after a parabolic move, I will not ...